SART3 Back

squamous cell carcinoma antigen recognized by T cells 3

External References:      Wikipedia GeneCards HUGO COSMIC Google Scholar

NCBI Description of SART3
The protein encoded by this gene is an RNA-binding nuclear protein that is a tumor-rejection antigen. This antigen possesses tumor epitopes capable of inducing HLA-A24-restricted and tumor-specific cytotoxic T lymphocytes in cancer patients and may be useful for specific immunotherapy. This gene product is found to be an important cellular factor for HIV-1 gene expression and viral replication. It also associates transiently with U6 and U4/U6 snRNPs during the recycling phase of the spliceosome cycle. This encoded protein is thought to be involved in the regulation of mRNA splicing.

Community Annotation of SART3 Add / Edit SART3: Annotations

No community annotations yet for SART3.
Sort mutations by: Tumor type  Mutation type  Position  
Straightedge cursor Expand

Figure notes


• "Mouse over" a mutation to see details.
• Missense green saturation indicates evolutionary conservation of the mutated positions.
• Red hashes in protein strip are splice sites.
• Blue-white-red bars are log2 copy ratio distributions (–1 to +1) from Zack et al. (2013).


Legend

SART3 is highly significantly mutated in
(none)
SART3 is significantly mutated in
(none)
SART3 is near significance in
(none)

Click on a tumor type to see its full list of significant genes.

Data details


• Mutation list for SART3